Reversible Cerebral Vasoconstriction Syndrome in the Setting of COVID-19 and Pleomorphic Sarcoma
- 30 November 2021
- journal article
- research article
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 27 (3) , 135-138
Abstract
Introduction: Reversible cerebral vasonstriction syndrome (RCVS) is an increasingly recognized clinical and radiologic syndrome. However, it has been rarely reported in the setting of the novel coronavirus disease-2019 (COVID-19) infection or sarcomatous tumors. RCVS might be the initial manifestations of COVID-19 infection or noncatecholamine producing masses including sarcoma. Case Report: A 44-year-old male who developed COVID-19–related symptoms followed by rapid onset of severe headaches in the setting of persistently elevated blood pressure (BP). Brain imaging showed multifocal arterial narrowing in the anterior and posterior circulation consistent with RCVS. Serial imaging demonstrated resolution of the arterial narrowing after BP control was achieved with improvement in the patient’s headaches. Further investigation for secondary causes of the patient’s elevated BP revealed a right renal mass, and the patient underwent right nephrectomy, and the biopsy results confirmed the diagnosis of pleomorphic sarcoma. Conclusion: Our case suggests a possible association between severe acute respiratory syndrome coronavirus 2 with development of RCVS, but further studies are needed to validate this observation, establish a causal relationship and define a pathophysiological mechanism. Considering tumors other than catecholamine-producing masses as a potential risk factor for developing RCVS might lead to earlier detection and treatment of any underlying malignancy in patients whom the main and sole presentation could be RCVS.Keywords
This publication has 14 references indexed in Scilit:
- Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological InsightsJournal of Stroke and Cerebrovascular Diseases, 2020
- COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral TransmissionGastroenterology, 2020
- RCVS 2 score and diagnostic approach for reversible cerebral vasoconstriction syndromeNeurology, 2019
- Hemorrhagic Reversible Cerebral Vasoconstriction SyndromeStroke, 2016
- Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical CourseAmerican Journal of Neuroradiology, 2015
- Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisalJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Reversible cerebral vasoconstriction syndromeThe Lancet Neurology, 2012
- Systematic review of reversible cerebral vasoconstriction syndromeExpert Review of Cardiovascular Therapy, 2010
- Narrative Review: Reversible Cerebral Vasoconstriction SyndromesAnnals of Internal Medicine, 2007
- Brain Angiotensin II: New Developments, Unanswered Questions and Therapeutic OpportunitiesCellular and Molecular Neurobiology, 2005